Jamjoom Pharmaceuticals Factory Company (4015.SR)
SAR 157.4
(-0.51%)
SAR 157.4
(-0.51%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 338.64 Million SAR | 55.61% |
| 2022 | 212.22 Million SAR | 6.04% |
| 2021 | 215.67 Million SAR | -27.29% |
| 2020 | 281.87 Million SAR | 33.75% |
| 2019 | 216.36 Million SAR | 1.29% |
| 2018 | 213.91 Million SAR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 95.67 Million SAR | -19.02% |
| 2024 Q1 | 124.28 Million SAR | 141.62% |
| 2024 Q2 | 114.03 Million SAR | -0.48% |
| 2023 Q4 | 51.87 Million SAR | -45.27% |
| 2023 FY | - SAR | 55.61% |
| 2023 Q3 | 94.77 Million SAR | -7.62% |
| 2023 Q2 | 102.59 Million SAR | 3.52% |
| 2023 Q1 | 99.1 Million SAR | 106.08% |
| 2022 Q2 | 54.07 Million SAR | -1.44% |
| 2022 Q1 | 54.86 Million SAR | -17.47% |
| 2022 FY | - SAR | 6.04% |
| 2022 Q4 | 48.09 Million SAR | -20.75% |
| 2022 Q3 | 60.68 Million SAR | 12.22% |
| 2021 FY | - SAR | -27.29% |
| 2021 Q4 | 66.47 Million SAR | 0.0% |
| 2021 Q3 | 66.47 Million SAR | 47.59% |
| 2021 Q2 | 45.03 Million SAR | 17.48% |
| 2021 Q1 | 38.33 Million SAR | 0.0% |
| 2020 FY | - SAR | 33.75% |
| 2019 FY | - SAR | 1.29% |
| 2018 FY | - SAR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Saudi Pharmaceutical Industries and Medical Appliances Corporation | 153.97 Million SAR | -119.944% |